Radiomics and blood biomarkers for predicting efficacy of sintilimab plus lenvatinib in advanced hepatocellular carcinoma. - Cui Y; Wang L; Li X; Wang K; Wang H; Bao Q; Zhu H; Gu X; Xing Q; Jin K; Sun Y; Xing B (Frontiers in immunology, 2026)